Page last updated: 2024-11-07

n-acetyl-s-(2-hydroxyethyl)cysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-acetyl-S-(2-hydroxyethyl)cysteine, also known as NAC, is a derivative of the amino acid cysteine. It is a potent antioxidant that is used to treat a variety of conditions, including acetaminophen overdose, chronic obstructive pulmonary disease (COPD), and infertility. NAC is thought to work by increasing levels of glutathione, a key antioxidant in the body. NAC is also being studied for its potential to prevent and treat cancer. NAC is a prodrug that is rapidly converted to cysteine in the body. Cysteine is a precursor to glutathione, which is a powerful antioxidant that helps to protect cells from damage caused by free radicals. NAC is also thought to have anti-inflammatory effects. NAC is available over-the-counter and by prescription. However, it is important to talk to your doctor before taking NAC, as it can interact with other medications.'

N-acetyl-S-(2-hydroxyethyl)cysteine: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID108009
CHEBI ID34960
SCHEMBL ID15794762
MeSH IDM0097969

Synonyms (24)

Synonym
15060-26-1
s-(2-hydroxyethyl)-n-acetyl-l-cysteine
2-hydroxyethylmercapturic acid
l-cysteine, n-acetyl-s-(2-hydroxyethyl)-
(2r)-2-acetamido-3-(2-hydroxyethylsulfanyl)propanoic acid
cysteine, n-acetyl-s-(2-hydroxyethyl)-
n-acetyl-s-2-hydroxyethyl-l-cysteine
19179-72-7
alanine, n-acetyl-3-((2-hydroxyethyl)thio)-
n-acetyl-s-(2-hydroxyethyl)cysteine
s-(beta-hydroxyethyl)mercapturic acid
unii-5125c7a0ek
5125c7a0ek ,
n-acetyl-s-(2-hydroxyethyl)-l-cysteine
s-(2-hydroxyethyl)-n-acetylcysteine
s-(.beta.-hydroxyethyl)mercapturic acid
alanine, n-acetyl-3-((2-hydroxyethyl)thio)-, l-
CHEBI:34960
SCHEMBL15794762
n -acetyl-s-(2-hydroxyethyl)-l-cysteine
DTXSID00914077
n-acetyl-s- (2-hydroxyethyl)-l-cysteine
Q27116339
(r)-2-acetamido-3-((2-hydroxyethyl)thio)propanoic acid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
", N-acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine (CHEMA) and N-acetyl-S-(2-hydroxyethyl)-L-cysteine (HEMA), were isolated from the urine of rats dosed with four successive doses of oxiranecarbonitrile (glycidonitrile, GN), 5 mg/kg, a reactive metabolic intermediate of acrylonitrile (AN)."( N-acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine, a new urinary metabolite of acrylonitrile and oxiranecarbonitrile.
Linhart, I; Novák, J; Smejkal, J, 1988
)
0.27
" Urinary CEMA levels show a clear dose-response relationship with daily cigarette consumption and urinary cotinine."( A column-switching liquid chromatography-tandem mass spectrometry method for quantitation of 2-cyanoethylmercapturic acid and 2-hydroxyethylmercapturic acid in Chinese smokers.
Gao, N; Hou, H; Hu, Q; Tang, G; Xiong, W; Zhang, X, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
N-acyl-amino acidA carboxamide resulting from the formal condensation of a carboxylic acid with the amino group of an amino acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (60.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's2 (20.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.65 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]